Traynor Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$643K Buy
2,708
+556
+26% +$116K 0.03% 173
2026
Q1
$444K Buy
2,152
+35
+2% +$7.54K 0.03% 192
2025
Q4
$435K Hold
2,117
0.02% 202
2025
Q3
$332K Buy
2,117
+17
+0.8% +$2.63K 0.02% 241
2025
Q2
$345K Hold
2,100
0.02% 164
2025
Q1
$289K Sell
2,100
-10
-0.5% -$1.27K 0.02% 164
2024
Q4
$250K Buy
2,110
+10
+0.5% +$1.17K 0.02% 207
2024
Q3
$232K Buy
2,100
+34
+2% +$3.56K 0.01% 214
2024
Q2
$203K Sell
2,066
-150
-7% -$15.3K 0.02% 222
2024
Q1
$248K Buy
2,216
+150
+7% +$16.2K 0.02% 204
2023
Q4
$208K Buy
+2,066
New +$205K 0.02% 196

Other funds holding CAH

Traynor Capital Management's CAH Position: Q2 2026 in Review

Traynor Capital Management increased its Cardinal Health (CAH) stake by 26% in Q2 2026, buying an estimated $116K and bringing the position to 2,708 shares worth $643K. The position accounts for 0.03% of the portfolio, ranked #173.

Traynor Capital Management first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 412 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Traynor Capital Management held 2,708 shares of Cardinal Health worth $643K as of Q2 2026.
  • Traynor Capital Management bought 556 Cardinal Health shares in Q2 2026, an estimated $116K.
  • Cardinal Health made up 0.03% of Traynor Capital Management's portfolio in Q2 2026, its #173 holding.
  • Traynor Capital Management first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 412 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.